- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01779648
Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis
The Influence of the Different Ways of Pneumatic Compression on Clinical and Physiologic Efficacies in Preventing Deep Vein Thrombosis: a Randomised Comparative Study
Various kinds of intermittent pneumatic compression devices (IPC) with particular ways of compression have been developed and used for prevention of deep vein thrombosis.
There are still some controversies about the physiologic properties and clinical impact of numerous issues including the variety of the cuff length, inflation rate, compression sequence, compression-relaxation cycle rate, and pressure generation characteristics.
This study is designed to compare clinical efficacies as well as venous hemodynamic improvements between Simultaneous bilateral compression with fixed venous refill time versus alternate compression with adjusted refill time
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 156-707
- SMG-SNU Boramae Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- the patients who undergo total knee replacement arthroplasty
Exclusion Criteria:
- (1) chronic superficial or deep venous insufficiency, (2) venous anomalies like duplication of the superficial femoral vein, (3) previous venous thromboembolism history, (4) being under anticoagulation therapy, (5) severe arteriosclerosis obliterans without palpable dorsalis pedis pulse, (6) open fracture, hemorrhagic condition, or extensive dermatitis at lower legs, (7) congestive heart failure. Additional exclusion criteria included a documented malignant tumor, because pharmacologic prophylaxis with anticoagulants would be more reasonable in this case.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Simultaneous compression+Fixed refill time
Simultaneous bilateral compression with fixed venous refill time through the whole duration of pneumatic compression
|
Other Names:
|
|
ACTIVE_COMPARATOR: Alternate compression+Adjusted refill time
alternate bilateral compression with adjusted venous refill time which would change several times during pneumatic compression
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Deep Vein Thrombosis
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Computed tomographic angiography were performed on 4th postoperative days to detect deep vein thrombosis and evaluate its extent and location.
|
On 4th postoperative days after total knee replacement arthroplasty
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Velocity
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared.
A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed.
Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded.
Under fixed state of other ultrasound scan parameters, peak velocity (PV) was measured by determination of maximum point of the augmented waveform.
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Mean Velocity
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared.
A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed.
Baseline velocity, flow pattern, and augmented flow of 11 seconds (Alternate compression arm) or 12 seconds (Simultaneous compression arm) were recorded.
This is an automatically measured mean value of venous flow.
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Peak Volume Flow
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared.
A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed.
Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded.
Peak volume flow (PVF) was automatically calculated with 1-second interval around the PV.
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Total Volume Flow
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared.
A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed.
Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded.
Total volume flow (TVF) was automatically calculated by the software.
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Expelled Total Volume
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Expelled volume was theoretically calculated value in order to figure out how much blood was squeezed by the compression for an hour; expelled total volume (ETV) = single cycle augmented TVF x cycling rate (cycles/hour).
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Expelled Peak Volume
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Expelled volume was theoretically calculated value in order to figure out how much blood was squeezed by the compression for an hour; expelled peak volume (EPV) = single cycle augmented PVF x cycling rate (cycles/hour).
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Augmented PV
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Enhanced peak velocity by application of intermittent pneumatic compression
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Augmented MV
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Enhanced mean velocity by application of pneumatic compression
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Augmented PVF
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
|
Enhanced peak volume flow by application of pneumatic compression
|
On 4th postoperative days after total knee replacement arthroplasty
|
|
Augmented TVF
Time Frame: on 4th postoperative day after total knee replacement arthroplasty
|
Enhanced total volume flow by application of pneumatic compression
|
on 4th postoperative day after total knee replacement arthroplasty
|
|
Cycling Rate
Time Frame: on 4th postoperative day after total knee replacement arthroplasty
|
Number of cuff inflation-deflation cycle during an hour.
In group SF, the cycling rate is fixed as 90 cycles/hour, but in group AA, it is variable according to the individual venous refill time.
|
on 4th postoperative day after total knee replacement arthroplasty
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jae-Sung Choi, Ph.D., SMG-SNU Boramae Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IPCDVT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Venous Thrombosis
-
Memorial Sloan Kettering Cancer CenterRecruitingVenous Thromboembolism | Deep Venous ThrombosisUnited States, Australia
-
Hospital de Clinicas de Porto AlegreCompletedDeep Venous Thromboses | Deep Venous Thrombosis of Left Leg | Deep Venous Thrombosis of Right Leg | Deep Venous Thrombosis Proximal
-
Merit Medical Systems, Inc.CompletedChronic Venous Thrombosis | Venous Thrombosis Upper Extremity | Venous Thrombosis Upper Extremity Superficial VeinsAustria, Germany, Italy
-
Intermountain Health Care, Inc.TerminatedDeep Vein Thrombosis | Venous Thromboembolism | Deep Venous Thrombosis | Thrombus | Upper Extremity Deep Venous ThrombosisUnited States
-
Intervene, Inc.RecruitingVenous ObstructionUnited Kingdom
-
Policlinico HospitalCompletedCentral Venous Catheter Thrombosis | Intensive Care Unit | Thrombosis, Venous | Central Venous CathetersItaly
-
Johns Hopkins UniversityPatient-Centered Outcomes Research InstituteCompletedVenous Thrombosis (Disorder)United States
-
W.L.Gore & AssociatesNot yet recruitingVenous Leg Ulcer | Venous Stasis | Venous Stenosis | Venous Occlusion | Venous Ulcer | Venous Thromboses | Venous Disease | Vein Thrombosis
-
Ain Shams UniversityCompleted
-
Milton S. Hershey Medical CenterEnrolling by invitation
Clinical Trials on DVT-3000
-
University Health Network, TorontoCompleted
-
Manchester University NHS Foundation TrustManchester Academic Health Science Centre; Firstkind LtdCompletedSepsis | Critical Illness | Venous Thromboembolism | Acute IllnessUnited Kingdom
-
University of Southern CaliforniaRecovery Force LLCCompletedVenous Thrombosis | Deep Vein ThrombosisUnited States
-
University Hospital, GrenobleSanofi; Ministry of Health, France; SFMV (Société Française de Médecine Vasculaire)CompletedVascular Diseases | Embolism and Thrombosis | Venous Insufficiency | Phlebitis | Pulmonary EmbolismFrance, Belgium, Guadeloupe
-
Ethicon Endo-SurgeryCompletedLaparoscopic Sleeve Gastrectomy (LSG) | Thoracic Lung Resection ProcedureUnited States
-
Xijing HospitalTang-Du Hospital; Air Force 986 HospitalCompleted
-
Sheba Medical CenterUnknown
-
Ain Shams UniversityEgyptian Chinese University; Teachers HospitalCompleted
-
PfizerCompleted